Why Catalyst Pharmaceuticals Stock Is Crashing Today
Shares of the rare-disease drugmaker Catalyst Pharmaceuticals (NASDAQ: CPRX) are under pressure Tuesday morning. Specifically, the biopharma's shares dropped by as much as 12.5% in pre-market trading today.
Catalyst's stock is sinking in response to the news that the company's effort to expand the label of its one and only approved drug, Firdapse, has failed for a second time in less than a year's time.
Image source: Getty Images.
Source Fool.com